The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.
Open accessAbstract
The ability of estrogens to stimulate the transcriptional activity of the estrogen receptor can be inhibited by a diverse range of estrogen antagonists. Here we show that the antiestrogen ICI 164,384, N-(n-butyl)-11-[3,17 beta-dihydroxy-estra-1,3,5(10)-trien-7 alpha-yl]N-methylundecanamide, rapidly reduces the levels of receptor protein transiently expressed in cells without affecting receptor mRNA abundance. The reduction in the levels of receptor protein is dose dependent, reversible by estradiol, and mediated by the hormone-binding domain of the receptor. Pulse-chase experiments indicate that the half-life of the receptor is reduced from approximately 5 hr in the presence of estradiol to less than 1 hr by ICI 164,384. A similar reduction in estrogen receptor levels is demonstrated in human breast cancer cells treated with ICI 164,384. We discuss the possibility that the increased turnover of the receptor might be a consequence of impaired receptor dimerization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Church, G. M., & Gilbert, W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1991 · Cited by 8,116
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Lehrach, H., Diamond, D., Wozney, J. M., & Boedtker, H. (1977) · Biochemistry · doi:10.1021/bi00640a033 · Cited by 3,415
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Firefly luciferase gene: structure and expression in mammalian cells.
de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.725 · Cited by 3,087
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
Kumar, V., & Chambon, P. (1988) · Cell · doi:10.1016/0092-8674(88)90017-7 · Cited by 1,220
The human estrogen receptor has two independent nonacidic transcriptional activation functions
Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E., & Chambon, P. (1989) · Cell · doi:10.1016/0092-8674(89)90031-7 · Cited by 1,048
Danielian, P. S., White, R., Lees, J. A., & Parker, M. G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05141.x · Cited by 803
Self-citationBerry, M., Metzger, D., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07469.x · Cited by 767
Fawell, S. (1990) · Cell · doi:10.1016/0092-8674(90)90343-d · Cited by 598
WEBSTER, N. (1988) · Cell · doi:10.1016/0092-8674(88)90552-1 · Cited by 580
Catelli, M. G., Binart, N., Jung-Testas, I., Renoir, J. M., Baulieu, E. E., Feramisco, J. R., & Welch, W. J. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04055.x · Cited by 516
Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex
Gaub, M.-P., Bellard, M., Scheuer, I., Chambon, P., & Sassone-Corsi, P. (1990) · Cell · doi:10.1016/0092-8674(90)90422-b · Cited by 468
Biochemical pharmacology of antiestrogen action.
Jordan, V. C. (1984) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06650-5 · Cited by 417
Fawell, S. E., White, R., Hoare, S., Sydenham, M., Page, M., & Parker, M. G. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6883 · Cited by 396
Self-citationStructural Organization and Expression of the Mouse Estrogen Receptor
White, R., Lees, J. A., Needham, M., Ham, J., & Parker, M. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-10-735 · Cited by 362
Self-citationHam, J., Thomson, A., Needham, M., Webb, P., & Parker, M. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.12.5263 · Cited by 339
Self-citationIdentification of two transactlvation domains in the mouse oestrogen receptor
Lees, J. A., Fawell, S. E., & Parker, M. G. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.14.5477 · Cited by 295
Self-citationAn amino-terminal fragment of GAL4 binds DNA as a dimer
Carey, M., Kakidani, H., Leatherwood, J., Mostashari, F., & Ptashne, M. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90007-7 · Cited by 281
Gottardis, M. M., Jiang, S.-T., Jeng, M., & Jordan, V. C. (1989) · PubMed · Cited by 247
Activation of the human beta-interferon gene requires an interferon-inducible factor.
Enoch, T., Zinn, K., & Maniatis, T. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.3.801 · Cited by 232
Novel steroidal pure antiestrogens
Bowler, J., Lilley, T. J., Pittam, J. D., & Wakeling, A. E. (1989) · Steroids · doi:10.1016/0039-128x(89)90076-7 · Cited by 206
GIBSON, M. K., NEMMERS, L. A., BECKMAN, W. C., DAVIS, V. L., CURTIS, S. W., & KORACH, K. S. (1991) · Endocrinology · doi:10.1210/endo-129-4-2000 · Cited by 198
Martinez, E., & Wahli, W. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08555.x · Cited by 167
Eckert, R. L., Mullick, A., Rorke, E. A., & Katzenellenbogen, B. S. (1984) · Endocrinology · doi:10.1210/endo-114-2-629 · Cited by 145
Regulation of gene expression by nuclear hormone receptors
Ham, J., & Parker, M. G. (1989) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(89)90012-4 · Cited by 130
Self-citationHuman estrogen receptor forms multiple protein-DNA complexes.
Brown, M. A., & Sharp, P. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38582-5 · Cited by 125
Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells
Wakeling, A. E., Newboult, E., & Peters, S. W. (1989) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0020225 · Cited by 112
Pham, T. A., Elliston, J. F., Nawaz, Z., McDonnell, D. P., Tsai, M., & O’Malley, B. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3125 · Cited by 97
Sabbah, M., Gouilleux, F., Sola, B., Redeuilh, G., & Baulieu, E. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.390 · Cited by 81
May, F. E. B., Johnson, M. D., Wiseman, L. R., Wakeling, A. E., Kastner, P., & Westley, B. R. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90406-8 · Cited by 69
Jamil, A., Croxtall, J. D., & WHITE, J. O. (1991) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0060215 · Cited by 69
Cited by
Induced protein degradation: an emerging drug discovery paradigm
Lai, A. C., & Crews, C. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.211 · Cited by 1,486
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Endocrine-responsive breast cancer and strategies for combating resistance
Ali, S., & Coombes, R. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc721 · Cited by 883
Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.
Cavaillès, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P. J., & Parker, M. G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00044.x · Cited by 751
Self-citationReid, G., Hübner, M. R., Métivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J., & Gannon, F. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00090-x · Cited by 732
Metadata
- Authors
- Dauvois, S., Danielian, P. S., White, R., & Parker, M. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-05
- Volume
- 89
- Issue
- 9
- Pages
- 4037-4041
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2148307287
- Cited by
- 465
- References
- 33
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.